As is published in the literature, in addition to a direct transcriptional role of GR on the tumor cells, which could be mediated by EMT pathways elevated in the GR-high group, the contribution of immune cells to outcomes should also be acknowledged because of a potential interaction of GR activity with the TME. This evidence concerns the gene NR3C1 and neoplasm.